CorMedix Inc.(CRMD)
Financials

Historical Financials

	DEC 2025	DEC 2024	DEC 2023	DEC 2022	DEC 2021	DEC 2020	DEC 2019	DEC 2018	DEC 2017	DEC 2016
Total Revenue	311,709,000	43,472,000	-	65,408	190,936	239,231	283,266	429,797	329,327	224,105
Cost of Revenue	22,089,000	3,034,000	-	3,734	148,938	204,846	373,234	396,786	114,964	366,673
Gross Profit	275,748,000	40,282,000	-	61,674	41,998	34,385	-89,968	33,011	214,363	-142,568

Create a free CapEdge account to access balance sheet, cash flow, and complete historical data.

		DEC 2025	DEC 2024	DEC 2023	DEC 2022	DEC 2021	DEC 2020	DEC 2019	DEC 2018	DEC 2017	DEC 2016
Gross Profit Margin (%)
R&D Expense
SG&A Expense
Total Operating Expenses
Operating Income or Loss
Operating Margin (%)
EBITDA
Interest Expense
Non-Operating Income/Expense
Income Before Tax
Income Tax Expense
Income from Continuing Ops.
Net Income
Net Profit Margin (%)
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares

	DEC 2025	DEC 2024	DEC 2023	DEC 2022	DEC 2021	DEC 2020	DEC 2019	DEC 2018	DEC 2017	DEC 2016
Total Revenue	311,709,000	43,472,000	-	65,408	190,936	239,231	283,266	429,797	329,327	224,105
Cost of Revenue	22,089,000	3,034,000	-	3,734	148,938	204,846	373,234	396,786	114,964	366,673
Gross Profit	275,748,000	40,282,000	-	61,674	41,998	34,385	-89,968	33,011	214,363	-142,568
Gross Profit Margin (%)
R&D Expense
SG&A Expense
Total Operating Expenses
Operating Income or Loss
Operating Margin (%)
EBITDA
Interest Expense
Non-Operating Income/Expense
Income Before Tax
Income Tax Expense
Income from Continuing Ops.
Net Income
Net Profit Margin (%)
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares

All numbers in thousands. Financial statements are in beta and sourced from EDGAR XBRL filings. Read the caveats.